Vor Bio To Participate In Upcoming Investor Conferences

2025-11-07 08:01:25

(MENAFN- GlobeNewsWire - Nasdaq) BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences:

TD Cowen Virtual Immunology & Inflammation Summit
Fireside Chat: Wednesday, November 12, 2025, at 2:30pm ET

8th Annual Evercore Healthcare Conference
Fireside Chat: Tuesday, December 2, 2025, 3:00pm ET
Location: Miami, FL

A live webcast and archived replay of the fireside chats will be available on the investors section of .

About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit .

Media & Investor Contacts:
Carl Mauch
...

Sarah Spencer
...

MENAFN07112025004107003653ID1110310748

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.